NTLA Intellia Therapeutics Inc

USD 11.97 -0.15 ( -1.24%)
Icon

Intellia Therapeutics Inc (NTLA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 11.97

-0.15 (-1.24%)

USD 1.50B

2.26M

USD 39.50(+229.99%)

USD 59.56 (+397.58%)

Icon

NTLA

Intellia Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 11.97
-0.15 ( -1.24%)

Intellia Therapeutics Inc (NTLA) Stock Forecast

Show ratings and price targets of :
USD 39.50
(+229.99%)

Based on the Intellia Therapeutics Inc stock forecast from 8 analysts, the average analyst target price for Intellia Therapeutics Inc is USD 39.50 over the next 12 months. Intellia Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Intellia Therapeutics Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Intellia Therapeutics Inc’s stock price was USD 11.97. Intellia Therapeutics Inc’s stock price has changed by -1.72% over the past week, -21.30% over the past month and -62.32% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...